Garry Pairaudeau
CEO, Co-Founder, DaltonTx
CEO and co-founder of DaltonTx, building the platform that will enable the pharma industry to bring more efficacious medicines to patients faster through the use of AI. Before founding DaltonTx I was CTO at Exscientia, leading the teams to build their technology platforms and the Milton Park automated lab. Earlier, three decades at AstraZeneca directing hit discovery and global chemistry strategy.
Events Garry Pairaudeau has spoken at
- Global Pharma Tech Summit 2026 18 May 2026 – 19 May 2026